Status:
ACTIVE_NOT_RECRUITING
Personalized Risk Stratification Model of Follicular Lymphoma Patients
Lead Sponsor:
Oncology Institute of Southern Switzerland
Collaborating Sponsors:
Azienda Ospedaliero Universitaria Maggiore della Carita
Azienda USL Reggio Emilia - IRCCS
Conditions:
Follicular Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
The study aims at developping and validating an integrated clinico-molecular model for an accurate identification of FL patients who are progression free and progressed, respectively, at 24 months aft...
Detailed Description
Already existing and coded tumor biological material and health-related personal data will be retrospectively collected. FL diagnosis will be confirmed by central pathology review. Tumor somatic mutat...
Eligibility Criteria
Inclusion
- Diagnosis of FL after January 1st, 2004 (chemoimmunotherapy era)
- Availability of tumor material collected before initiation of medical therapy
- Availability of the baseline and follow-up annotations
Exclusion
- None.
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2026
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT03436602
Start Date
March 1 2018
End Date
October 31 2026
Last Update
November 18 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Arcispedale Santa Maria Nuova, AUSL IRCSS, Hematology Department
Reggio Emilia, RE, Italy, 42123
2
Azienda Ospedaliera Universitaria Maggiore della Carità
Novara, Italy, 28100
3
Institute of Oncology Research
Bellinzona, Canton Ticino, Switzerland, 6500
4
Institute of Pathology
Locarno, Canton Ticino, Switzerland